The Procter & Gamble Company (NYSE:PG) Shares Acquired by BerganKDV Wealth Management LLC

BerganKDV Wealth Management LLC boosted its stake in The Procter & Gamble Company (NYSE:PG) by 5.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 33,060 shares of the company’s stock after purchasing an additional 1,595 shares during the period. BerganKDV Wealth Management LLC’s holdings in The Procter & Gamble were worth $4,461,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently modified their holdings of PG. Paragon Wealth Strategies LLC acquired a new position in The Procter & Gamble in the 2nd quarter valued at about $33,000. KB Financial Partners LLC acquired a new position in The Procter & Gamble during the 1st quarter worth approximately $41,000. Aspire Private Capital LLC increased its position in The Procter & Gamble by 85.3% during the 1st quarter. Aspire Private Capital LLC now owns 430 shares of the company’s stock worth $58,000 after purchasing an additional 198 shares during the period. Cowen Prime Advisors LLC acquired a new position in The Procter & Gamble during the 2nd quarter worth approximately $67,000. Finally, Wagner Wealth Management LLC purchased a new stake in shares of The Procter & Gamble during the 1st quarter worth approximately $79,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Shares of PG stock traded up $0.19 on Wednesday, reaching $145.62. 225,598 shares of the stock were exchanged, compared to its average volume of 7,949,646. The stock has a market cap of $353.61 billion, a P/E ratio of 26.49, a price-to-earnings-growth ratio of 3.47 and a beta of 0.43. The company has a quick ratio of 0.52, a current ratio of 0.70 and a debt-to-equity ratio of 0.50. The firm has a 50 day moving average of $141.87 and a two-hundred day moving average of $136.63. The Procter & Gamble Company has a 1-year low of $121.54 and a 1-year high of $147.23.

The Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Thursday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.05. The Procter & Gamble had a return on equity of 31.49% and a net margin of 18.80%. The firm had revenue of $18.95 billion during the quarter, compared to the consensus estimate of $18.38 billion. During the same period in the prior year, the firm earned $1.16 EPS. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. On average, equities research analysts predict that The Procter & Gamble Company will post 5.94 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Monday, August 16th. Investors of record on Friday, July 23rd were issued a $0.8698 dividend. This is an increase from The Procter & Gamble’s previous quarterly dividend of $0.66. This represents a $3.48 annualized dividend and a yield of 2.39%. The ex-dividend date of this dividend was Thursday, July 22nd. The Procter & Gamble’s dividend payout ratio is currently 61.48%.

In other The Procter & Gamble news, CFO Andre Schulten sold 1,010 shares of the company’s stock in a transaction dated Tuesday, August 17th. The shares were sold at an average price of $144.37, for a total value of $145,813.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Carolyn M. Tastad sold 7,772 shares of the company’s stock in a transaction dated Monday, August 2nd. The shares were sold at an average price of $141.77, for a total transaction of $1,101,836.44. The disclosure for this sale can be found here. Over the last quarter, insiders sold 748,024 shares of company stock valued at $106,760,698. 0.51% of the stock is owned by insiders.

PG has been the topic of a number of recent research reports. UBS Group initiated coverage on The Procter & Gamble in a research note on Wednesday, June 23rd. They issued a “neutral” rating and a $138.00 target price on the stock. Evercore ISI reaffirmed a “buy” rating and issued a $163.00 target price on shares of The Procter & Gamble in a research note on Sunday. Zacks Investment Research raised The Procter & Gamble from a “hold” rating to a “buy” rating and set a $149.00 target price on the stock in a research note on Tuesday, July 20th. Morgan Stanley upped their target price on The Procter & Gamble from $160.00 to $161.00 and gave the company an “overweight” rating in a research note on Tuesday, September 7th. Finally, Royal Bank of Canada upped their target price on The Procter & Gamble from $130.00 to $139.00 and gave the company a “sector perform” rating in a research note on Monday, August 2nd. Ten investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $151.63.

The Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment comprises of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Article: Strangles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG).

Institutional Ownership by Quarter for The Procter & Gamble (NYSE:PG)

Receive News & Ratings for The Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.